A recent report studying the outcomes of mesothelioma patients over a three-year period has found the best treatment for patients is a combination of lung-saving surgery followed by chemotherapy and light treatment.
Compared to patients receiving only chemotherapy as treatment for mesothelioma, those who received the combination therapy lived up to two years longer.
The study was based on 73 patients with advanced mesothelioma, they all received the surgery followed by light treatment which kills remaining cancer cells surgery cannot reach. Ninety-two percent of participants also underwent chemotherapy. On average the patients lived for almost three years after the treatment, compared to the 12 to 21 months average life expectancy of those who are treated solely with chemotherapy.
Patients in the study whose mesothelioma had not spread to the lymph nodes fared even better, living an average of 7.3 years after treatment. Read more about this study here.
Mesothelioma Research News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.